Finzati - Logo
BIXT logo

Bioxytran, Inc.

BIXT • Biotechnology
$0.02
▲ +0.00 (+3.86%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.40M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.16Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.02
Change3.86%
Shares Out114.36M
Market Cap$2.40M
Enterprise Value$3.25M
52W Range0.02 - 0.09
Beta1.97
P/E-0.69
P/FCF-2.77
EV/EBITDA-1.02
EV/FCF-3.75
Earnings Yield-145.62%

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.16Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/5/2010
Industry: Biotechnology
P/B i: -2.69
Debt / Equity i: -0.33
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.33
Current Ratio: 0.16
Quick Ratio: 0.16
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Hoberman Alan M
Transaction: 11/18/2025
BUY
Change
+210,000
Price
$0.60
Filing
11/18/2025
Type
BUY
Utter Anders
Transaction: 11/14/2025
BUY
Change
+38,588
Price
$0.35
Filing
11/18/2025
Type
BUY
CONAWAY DALE H
Transaction: 11/14/2025
BUY
Change
+38,588
Price
$0.35
Filing
11/18/2025
Type
BUY